nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—MAP3K9—brain—conduct disorder	0.0401	0.066	CbGeAlD
Pazopanib—TAOK1—brain—conduct disorder	0.0301	0.0495	CbGeAlD
Pazopanib—SH2B3—brain—conduct disorder	0.0284	0.0466	CbGeAlD
Pazopanib—AURKC—brain—conduct disorder	0.0279	0.0459	CbGeAlD
Pazopanib—PLK4—brain—conduct disorder	0.0255	0.042	CbGeAlD
Pazopanib—STK16—brain—conduct disorder	0.0241	0.0397	CbGeAlD
Pazopanib—LYN—brain—conduct disorder	0.0239	0.0392	CbGeAlD
Pazopanib—FGFR3—brain—conduct disorder	0.0237	0.039	CbGeAlD
Pazopanib—RIOK2—brain—conduct disorder	0.0237	0.039	CbGeAlD
Pazopanib—MAP3K19—brain—conduct disorder	0.0235	0.0387	CbGeAlD
Pazopanib—BMPR1B—brain—conduct disorder	0.0235	0.0387	CbGeAlD
Pazopanib—STK36—brain—conduct disorder	0.0213	0.0351	CbGeAlD
Pazopanib—PI4KB—brain—conduct disorder	0.021	0.0345	CbGeAlD
Pazopanib—LIMK2—brain—conduct disorder	0.0206	0.0339	CbGeAlD
Pazopanib—FLT4—brain—conduct disorder	0.0185	0.0305	CbGeAlD
Pazopanib—PIP4K2C—brain—conduct disorder	0.0184	0.0303	CbGeAlD
Pazopanib—FGFR1—brain—conduct disorder	0.0183	0.0301	CbGeAlD
Pazopanib—MAP3K2—brain—conduct disorder	0.0175	0.0287	CbGeAlD
Pazopanib—FGF1—brain—conduct disorder	0.0165	0.0271	CbGeAlD
Pazopanib—FGFR2—brain—conduct disorder	0.0155	0.0256	CbGeAlD
Pazopanib—FLT1—brain—conduct disorder	0.0144	0.0237	CbGeAlD
Pazopanib—EPHB6—brain—conduct disorder	0.0142	0.0234	CbGeAlD
Pazopanib—STK10—brain—conduct disorder	0.0136	0.0224	CbGeAlD
Pazopanib—TAOK3—brain—conduct disorder	0.0136	0.0223	CbGeAlD
Pazopanib—PDGFRA—brain—conduct disorder	0.0135	0.0222	CbGeAlD
Pazopanib—KDR—brain—conduct disorder	0.0122	0.02	CbGeAlD
Pazopanib—MAP2K5—brain—conduct disorder	0.0122	0.02	CbGeAlD
Pazopanib—CSF1R—brain—conduct disorder	0.0119	0.0195	CbGeAlD
Pazopanib—KIT—brain—conduct disorder	0.0108	0.0177	CbGeAlD
Pazopanib—PDGFRB—brain—conduct disorder	0.0105	0.0173	CbGeAlD
Pazopanib—CYP2C8—brain—conduct disorder	0.00609	0.01	CbGeAlD
Pazopanib—ABCG2—brain—conduct disorder	0.00592	0.00974	CbGeAlD
Pazopanib—CYP2D6—brain—conduct disorder	0.00406	0.00668	CbGeAlD
Pazopanib—ABCB1—brain—conduct disorder	0.00292	0.0048	CbGeAlD
Pazopanib—SH2B3—Signaling Pathways—WASF1—conduct disorder	0.00217	0.00553	CbGpPWpGaD
Pazopanib—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00217	0.00553	CbGpPWpGaD
Pazopanib—ITK—Immune System—WASF1—conduct disorder	0.00216	0.00551	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—MB21D1—conduct disorder	0.00216	0.0055	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—MB21D1—conduct disorder	0.00215	0.00549	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00214	0.00545	CbGpPWpGaD
Pazopanib—KIT—Kit receptor signaling pathway—EP300—conduct disorder	0.0021	0.00536	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—WASF1—conduct disorder	0.00208	0.0053	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—POLR3A—conduct disorder	0.00205	0.00524	CbGpPWpGaD
Pazopanib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.002	0.00511	CbGpPWpGaD
Pazopanib—PDGFRA—ATF-2 transcription factor network—EP300—conduct disorder	0.00199	0.00508	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—MB21D1—conduct disorder	0.00196	0.005	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—MB21D1—conduct disorder	0.00194	0.00495	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—MB21D1—conduct disorder	0.0019	0.00484	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—CGA—conduct disorder	0.00187	0.00478	CbGpPWpGaD
Pazopanib—LYN—Kit receptor signaling pathway—EP300—conduct disorder	0.00176	0.00448	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—WASF1—conduct disorder	0.00173	0.00441	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—CGA—conduct disorder	0.00171	0.00437	CbGpPWpGaD
Pazopanib—PDGFRB—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.0017	0.00434	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—POLR3A—conduct disorder	0.0017	0.00433	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—POLR3A—conduct disorder	0.00167	0.00426	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00164	0.0042	CbGpPWpGaD
Pazopanib—FGF1—Immune System—MB21D1—conduct disorder	0.00163	0.00416	CbGpPWpGaD
Pazopanib—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00163	0.00415	CbGpPWpGaD
Pazopanib—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00162	0.00412	CbGpPWpGaD
Pazopanib—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00161	0.00409	CbGpPWpGaD
Pazopanib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0016	0.00409	CbGpPWpGaD
Pazopanib—KIT—C-MYB transcription factor network—EP300—conduct disorder	0.00158	0.00404	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—POLR3A—conduct disorder	0.00158	0.00404	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—POLR3A—conduct disorder	0.00158	0.00403	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—MB21D1—conduct disorder	0.00156	0.00397	CbGpPWpGaD
Pazopanib—SH2B3—Hemostasis—EP300—conduct disorder	0.00154	0.00394	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00153	0.00391	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00153	0.0039	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—DRD4—conduct disorder	0.00151	0.00386	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—WASF1—conduct disorder	0.0015	0.00383	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—POLR3A—conduct disorder	0.00144	0.00367	CbGpPWpGaD
Pazopanib—TAOK1—Cell Cycle, Mitotic—EP300—conduct disorder	0.00143	0.00366	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—WASF1—conduct disorder	0.00143	0.00365	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—POLR3A—conduct disorder	0.00142	0.00363	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—WASF1—conduct disorder	0.0014	0.00358	CbGpPWpGaD
Pazopanib—LCK—Notch Signaling Pathway—EP300—conduct disorder	0.0014	0.00357	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—POLR3A—conduct disorder	0.00139	0.00355	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00138	0.00351	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—WASF1—conduct disorder	0.00137	0.0035	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—MB21D1—conduct disorder	0.00135	0.00344	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—WASF1—conduct disorder	0.00133	0.0034	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—WASF1—conduct disorder	0.00133	0.00339	CbGpPWpGaD
Pazopanib—KIT—Immune System—MB21D1—conduct disorder	0.00132	0.00338	CbGpPWpGaD
Pazopanib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00132	0.00335	CbGpPWpGaD
Pazopanib—TAOK1—Cell Cycle—EP300—conduct disorder	0.00128	0.00327	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—CGA—conduct disorder	0.00128	0.00326	CbGpPWpGaD
Pazopanib—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00127	0.00325	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00127	0.00324	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—MB21D1—conduct disorder	0.00126	0.00321	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—MB21D1—conduct disorder	0.00125	0.0032	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—COMT—conduct disorder	0.00124	0.00317	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—MAOA—conduct disorder	0.00123	0.00314	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—WASF1—conduct disorder	0.00121	0.00309	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—WASF1—conduct disorder	0.0012	0.00306	CbGpPWpGaD
Pazopanib—FGF1—Immune System—POLR3A—conduct disorder	0.0012	0.00305	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0012	0.00305	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—WASF1—conduct disorder	0.00117	0.00299	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—POLR3A—conduct disorder	0.00114	0.00291	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00113	0.00289	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—MB21D1—conduct disorder	0.00113	0.00288	CbGpPWpGaD
Pazopanib—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00111	0.00284	CbGpPWpGaD
Pazopanib—LYN—Immune System—MB21D1—conduct disorder	0.00111	0.00282	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—DRD4—conduct disorder	0.00105	0.00268	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00105	0.00267	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—WASF1—conduct disorder	0.00102	0.00261	CbGpPWpGaD
Pazopanib—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00102	0.0026	CbGpPWpGaD
Pazopanib—FGF1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00101	0.00258	CbGpPWpGaD
Pazopanib—FGF1—Immune System—WASF1—conduct disorder	0.00101	0.00257	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—POLR3A—conduct disorder	0.000989	0.00252	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—HTR2A—conduct disorder	0.000988	0.00252	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CGA—conduct disorder	0.000977	0.00249	CbGpPWpGaD
Pazopanib—KIT—Immune System—POLR3A—conduct disorder	0.000972	0.00248	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—WASF1—conduct disorder	0.000961	0.00245	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—DRD4—conduct disorder	0.00096	0.00245	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—POLR3A—conduct disorder	0.000922	0.00235	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—POLR3A—conduct disorder	0.00092	0.00235	CbGpPWpGaD
Pazopanib—LCK—Immune System—MB21D1—conduct disorder	0.000906	0.00231	CbGpPWpGaD
Pazopanib—ITK—Innate Immune System—EP300—conduct disorder	0.000896	0.00229	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CGA—conduct disorder	0.000873	0.00223	CbGpPWpGaD
Pazopanib—LIMK2—Developmental Biology—EP300—conduct disorder	0.000862	0.0022	CbGpPWpGaD
Pazopanib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00086	0.00219	CbGpPWpGaD
Pazopanib—CYP2C8—Biological oxidations—COMT—conduct disorder	0.000857	0.00219	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CGA—conduct disorder	0.000851	0.00217	CbGpPWpGaD
Pazopanib—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.000851	0.00217	CbGpPWpGaD
Pazopanib—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.000845	0.00216	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—WASF1—conduct disorder	0.000833	0.00212	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—POLR3A—conduct disorder	0.000829	0.00211	CbGpPWpGaD
Pazopanib—KIT—Immune System—WASF1—conduct disorder	0.000818	0.00209	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CGA—conduct disorder	0.000812	0.00207	CbGpPWpGaD
Pazopanib—LYN—Immune System—POLR3A—conduct disorder	0.000811	0.00207	CbGpPWpGaD
Pazopanib—EPHB6—Developmental Biology—EP300—conduct disorder	0.000811	0.00207	CbGpPWpGaD
Pazopanib—PLK4—Cell Cycle, Mitotic—EP300—conduct disorder	0.000783	0.002	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—WASF1—conduct disorder	0.000783	0.002	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00078	0.00199	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000778	0.00198	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—WASF1—conduct disorder	0.000776	0.00198	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—WASF1—conduct disorder	0.000774	0.00198	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000734	0.00187	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000734	0.00187	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000729	0.00186	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—DRD4—conduct disorder	0.000716	0.00183	CbGpPWpGaD
Pazopanib—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000704	0.00179	CbGpPWpGaD
Pazopanib—PLK4—Cell Cycle—EP300—conduct disorder	0.0007	0.00179	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—WASF1—conduct disorder	0.0007	0.00179	CbGpPWpGaD
Pazopanib—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000699	0.00178	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—WASF1—conduct disorder	0.000697	0.00178	CbGpPWpGaD
Pazopanib—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000694	0.00177	CbGpPWpGaD
Pazopanib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000689	0.00176	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—HTR2A—conduct disorder	0.000685	0.00175	CbGpPWpGaD
Pazopanib—LYN—Immune System—WASF1—conduct disorder	0.000683	0.00174	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—WASF1—conduct disorder	0.000682	0.00174	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CGA—conduct disorder	0.000672	0.00171	CbGpPWpGaD
Pazopanib—LCK—Immune System—POLR3A—conduct disorder	0.000665	0.0017	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CGA—conduct disorder	0.00066	0.00168	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—WASF1—conduct disorder	0.000651	0.00166	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—HTR2A—conduct disorder	0.000626	0.0016	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CGA—conduct disorder	0.000626	0.0016	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CGA—conduct disorder	0.000625	0.00159	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CGA—conduct disorder	0.000617	0.00157	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000596	0.00152	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000592	0.00151	CbGpPWpGaD
Pazopanib—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000588	0.0015	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000566	0.00144	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CGA—conduct disorder	0.000565	0.00144	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CGA—conduct disorder	0.000563	0.00144	CbGpPWpGaD
Pazopanib—LCK—Immune System—WASF1—conduct disorder	0.00056	0.00143	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CGA—conduct disorder	0.000551	0.00141	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—DRD4—conduct disorder	0.000547	0.0014	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—WASF1—conduct disorder	0.000538	0.00137	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—EP300—conduct disorder	0.000532	0.00136	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—WASF1—conduct disorder	0.000529	0.00135	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—EP300—conduct disorder	0.000523	0.00134	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CGA—conduct disorder	0.000523	0.00133	CbGpPWpGaD
Pazopanib—ITK—Immune System—EP300—conduct disorder	0.000522	0.00133	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000507	0.00129	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—EP300—conduct disorder	0.000502	0.00128	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—WASF1—conduct disorder	0.000502	0.00128	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—WASF1—conduct disorder	0.000501	0.00128	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—EP300—conduct disorder	0.000495	0.00126	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—DRD4—conduct disorder	0.000489	0.00125	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—DRD4—conduct disorder	0.000477	0.00122	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—HTR2A—conduct disorder	0.000467	0.00119	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00046	0.00117	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000457	0.00117	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD4—conduct disorder	0.000455	0.00116	CbGpPWpGaD
Pazopanib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000454	0.00116	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CGA—conduct disorder	0.000452	0.00115	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—WASF1—conduct disorder	0.000451	0.00115	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—WASF1—conduct disorder	0.000442	0.00113	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—EP300—conduct disorder	0.000417	0.00106	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD4—conduct disorder	0.000376	0.00096	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD4—conduct disorder	0.00037	0.000943	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—EP300—conduct disorder	0.000364	0.00093	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—EP300—conduct disorder	0.000363	0.000926	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—WASF1—conduct disorder	0.000362	0.000923	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HTR2A—conduct disorder	0.000357	0.000911	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD4—conduct disorder	0.000351	0.000895	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD4—conduct disorder	0.00035	0.000892	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—EP300—conduct disorder	0.000345	0.000881	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—EP300—conduct disorder	0.000339	0.000865	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—EP300—conduct disorder	0.000332	0.000847	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CGA—conduct disorder	0.000325	0.000828	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—EP300—conduct disorder	0.000322	0.000821	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—EP300—conduct disorder	0.000321	0.000819	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—EP300—conduct disorder	0.000321	0.000818	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HTR2A—conduct disorder	0.000319	0.000814	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD4—conduct disorder	0.000315	0.000804	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—EP300—conduct disorder	0.000315	0.000802	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HTR2A—conduct disorder	0.000311	0.000793	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD4—conduct disorder	0.000309	0.000787	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HTR2A—conduct disorder	0.000297	0.000757	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000294	0.000751	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—EP300—conduct disorder	0.000292	0.000746	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—EP300—conduct disorder	0.000289	0.000738	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—EP300—conduct disorder	0.000283	0.000722	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CGA—conduct disorder	0.000283	0.000722	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—COMT—conduct disorder	0.000278	0.00071	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—MAOA—conduct disorder	0.000276	0.000705	CbGpPWpGaD
Pazopanib—FGFR3—Disease—EP300—conduct disorder	0.00027	0.000689	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CGA—conduct disorder	0.000267	0.00068	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—EP300—conduct disorder	0.000258	0.000658	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—COMT—conduct disorder	0.000255	0.000651	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000253	0.000646	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD4—conduct disorder	0.000253	0.000645	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—EP300—conduct disorder	0.000248	0.000632	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000246	0.000627	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR2A—conduct disorder	0.000245	0.000626	CbGpPWpGaD
Pazopanib—FGF1—Immune System—EP300—conduct disorder	0.000243	0.00062	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR2A—conduct disorder	0.000241	0.000615	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—COMT—conduct disorder	0.000236	0.000602	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MAOA—conduct disorder	0.000234	0.000598	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—EP300—conduct disorder	0.000232	0.000592	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR2A—conduct disorder	0.000229	0.000584	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR2A—conduct disorder	0.000228	0.000582	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CGA—conduct disorder	0.000226	0.000576	CbGpPWpGaD
Pazopanib—FGF1—Disease—EP300—conduct disorder	0.000224	0.000572	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR2A—conduct disorder	0.000206	0.000525	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR2A—conduct disorder	0.000201	0.000514	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—EP300—conduct disorder	0.000201	0.000513	CbGpPWpGaD
Pazopanib—KIT—Immune System—EP300—conduct disorder	0.000198	0.000504	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EP300—conduct disorder	0.000189	0.000482	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EP300—conduct disorder	0.000187	0.000478	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EP300—conduct disorder	0.000187	0.000477	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EP300—conduct disorder	0.000186	0.000474	CbGpPWpGaD
Pazopanib—KIT—Disease—EP300—conduct disorder	0.000182	0.000465	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CGA—conduct disorder	0.000174	0.000445	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EP300—conduct disorder	0.000173	0.000442	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EP300—conduct disorder	0.000173	0.00044	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EP300—conduct disorder	0.000169	0.000431	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EP300—conduct disorder	0.000168	0.00043	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—conduct disorder	0.000165	0.000421	CbGpPWpGaD
Pazopanib—LYN—Immune System—EP300—conduct disorder	0.000165	0.000421	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EP300—conduct disorder	0.000165	0.00042	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EP300—conduct disorder	0.000157	0.000401	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EP300—conduct disorder	0.000156	0.000397	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—COMT—conduct disorder	0.000147	0.000374	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOA—conduct disorder	0.000146	0.000371	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000141	0.00036	CbGpPWpGaD
Pazopanib—LCK—Immune System—EP300—conduct disorder	0.000135	0.000345	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EP300—conduct disorder	0.00013	0.000332	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EP300—conduct disorder	0.000128	0.000326	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—COMT—conduct disorder	0.000128	0.000326	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOA—conduct disorder	0.000127	0.000323	CbGpPWpGaD
Pazopanib—LCK—Disease—EP300—conduct disorder	0.000125	0.000318	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EP300—conduct disorder	0.000121	0.000309	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EP300—conduct disorder	0.000121	0.000308	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—COMT—conduct disorder	0.00012	0.000307	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOA—conduct disorder	0.000119	0.000305	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—EP300—conduct disorder	0.000119	0.000304	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—EP300—conduct disorder	0.000109	0.000279	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EP300—conduct disorder	0.000109	0.000278	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EP300—conduct disorder	0.000107	0.000272	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—COMT—conduct disorder	0.000102	0.00026	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—EP300—conduct disorder	0.000101	0.000258	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOA—conduct disorder	0.000101	0.000258	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	9.81e-05	0.00025	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EP300—conduct disorder	8.74e-05	0.000223	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—COMT—conduct disorder	7.87e-05	0.000201	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOA—conduct disorder	7.81e-05	0.000199	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—EP300—conduct disorder	6.28e-05	0.00016	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—EP300—conduct disorder	5.48e-05	0.00014	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—EP300—conduct disorder	5.16e-05	0.000132	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—EP300—conduct disorder	4.37e-05	0.000112	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—EP300—conduct disorder	3.37e-05	8.61e-05	CbGpPWpGaD
